Pfizer Expands in Cancer With $10.6 Billion Deal for Array

(Bloomberg) -- Pfizer Inc. will buy Array BioPharma Inc. for $10.6 billion to gain its promising new medicines for cancer, which could end or limit the use of punishing chemotherapy for some patien...

Bloomberg Quint

Add BloombergQuint App to Home screen.